GlassScriptPhysician profile
Nicole Stapley
NPI 1063898377
$1,369.32
in general payments reported to CMS, 2019-2025
29 companies · $237 in 2025
The $237 reported for 2025 was more than what 79% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $334 · 2023: $255 · 2024: $245 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $187.54 | 2021-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Merck Sharp & Dohme LLC | $130.82 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.66 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $100.12 | 2021-2025 | Wegovy |
| Dynavax Technologies Corporation | $94.79 | 2022-2025 | Heplisav-B |
| Biohaven Pharmaceutical Holding Company LTD. | $78.95 | 2022 | |
| Amarin Pharma, INC. | $69.87 | 2021-2022 | |
| Abbvie INC. | $65.61 | 2021-2024 | |
| Pfizer INC. | $62.70 | 2021-2024 | |
| Cranial Technologies, INC | $53.91 | 2022-2025 | Doc Band |
| Inspire Medical Systems, INC. | $42.51 | 2024-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $39.73 | 2024-2025 | |
| Genentech USA, INC. | $35.84 | 2021 | |
| Lilly USA, LLC | $26.96 | 2023-2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $24.57 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.03 | 2024 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $23.27 | 2023 | |
| Edwards Lifesciences Corporation | $22.24 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.32 | 2024 | Caplyta |
| Ironshore Pharmaceuticals INC. | $19.31 | 2023 | Jornay Pm |
| Biohaven Pharmaceuticals, INC. | $18.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.68 | 2024 | Flumist Quadrivalent |
| Kaleo, INC. | $13.99 | 2023 | Auvi-Q |
| Corium, LLC | $12.82 | 2024 | Azstarys |
| Janssen Pharmaceuticals, INC | $12.69 | 2021 | |
| Idorsia Pharmaceuticals US INC | $12.51 | 2022 | |
| Sobi, INC | $12.39 | 2022 | |
| Medtronic, INC. | $12.28 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Stapley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.